Troubled blood-testing startup Theranos acknowledged that it is under investigation by several regulators and agencies.
The investigations follow a series of articles by The Wall Street Journal in which former employees said the company’s tests, which use only a few drops of blood, were unreliable. Theranos called the articles were inaccurate when they were published.
Theranos said in a letter Monday that investigations or inspections have been opened by the Centers for Medicare and Medicaid Services, the Securities Exchange Commission and the U.S. Attorney’s Office for the Northern District of California. It said investigations by the Food and Drug Administration and the Departments of Health in Arizona and Pennsylvania were closed successfully.
Founder and CEO Elizabeth Holmes told NBC News in an interview that aired Monday that she was “devastated” that the company didn’t catch and fix issues sooner after the Centers for Medicare and Medicaid Services found that one of its labs had unqualified workers.
